The Clinical Relevance of Minor Paroxysmal Nocturnal Hemoglobinuria Clones in Refractory Cytopenia of Childhood: a Prospective Study by EWOG-MDS

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2013 Jun 29

PMID 23807769

Citations 9

Authors

A M Aalbers

V H J van der Velden

A Yoshimi

A Fischer

P Noellke

C M Zwaan

I Baumann

H B Beverloo

M Dworzak

H Hasle

F Locatelli

B De Moerloose

G Gohring

M Schmugge

J Stary

M Zecca

A W Langerak

J J M van Dongen

R Pieters

C M Niemeyer

M M van den Heuvel-Eibrink

Affiliations

Soon will be listed here.

Citing Articles

Case Report: Refractory Cytopenia With a Switch From a Transient Monosomy 7 to a Disease-Ameliorating del(20q) in a -Deficient Long-term Survivor.

Poyer F, Heredia R, Novak W, Zeitlhofer P, Nebral K, Dworzak M Front Immunol. 2022; 13:869047.

PMID: 35812385 PMC: 9263211. DOI: 10.3389/fimmu.2022.869047.

The predictive value of PNH clones, 6p CN-LOH, and clonal TCR gene rearrangement for aplastic anemia diagnosis.

Shah Y, Priore S, Li Y, Tang C, Nicholas P, Kurre P Blood Adv. 2021; 5(16):3216-3226.

PMID: 34427585 PMC: 8405198. DOI: 10.1182/bloodadvances.2021004201.

Laboratory studies for paroxysmal nocturnal hemoglobinuria, with emphasis on flow cytometry.

Lima M Pract Lab Med. 2020; 20:e00158.

PMID: 32195308 PMC: 7078534. DOI: 10.1016/j.plabm.2020.e00158.

Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group.

Hebeda K, Tzankov A, Boudova L, Saft L, Hasserjian R, de Boer M Pathobiology. 2018; 86(1):62-75.

PMID: 29982244 PMC: 6482987. DOI: 10.1159/000489678.

Myelodysplastic and myeloproliferative disorders of childhood.

Hasle H Hematology Am Soc Hematol Educ Program. 2016; 2016(1):598-604.

PMID: 27913534 PMC: 6142519. DOI: 10.1182/asheducation-2016.1.598.

References

Yoshimi A, Niemeyer C, Fuhrer M, Strahm B . Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children. Blood. 2013; 121(5):860-1. DOI: 10.1182/blood-2012-10-461509. View

Wang H, Chuhjo T, Yasue S, Omine M, Nakao S . Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome. Blood. 2002; 100(12):3897-902. DOI: 10.1182/blood-2002-03-0799. View

Yoshimi A, Baumann I, Fuhrer M, Bergstrasser E, Gobel U, Sykora K . Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia. Haematologica. 2007; 92(3):397-400. DOI: 10.3324/haematol.10683. View

Niemeyer C, Baumann I . Classification of childhood aplastic anemia and myelodysplastic syndrome. Hematology Am Soc Hematol Educ Program. 2011; 2011:84-9. DOI: 10.1182/asheducation-2011.1.84. View

Timeus F, Crescenzio N, Lorenzati A, Doria A, Foglia L, Pagliano S . Paroxysmal nocturnal haemoglobinuria clones in children with acquired aplastic anaemia: a prospective single centre study. Br J Haematol. 2010; 150(4):483-5. DOI: 10.1111/j.1365-2141.2010.08219.x. View

Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu C . Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med. 2011; 365(5):430-8. PMC: 3721503. DOI: 10.1056/NEJMoa1103975. View

Dunn D, Tanawattanacharoen P, Boccuni P, Nagakura S, Green S, Kirby M . Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med. 1999; 131(6):401-8. DOI: 10.7326/0003-4819-131-6-199909210-00002. View

Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R . Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005; 106(12):3699-709. PMC: 1895106. DOI: 10.1182/blood-2005-04-1717. View

Dallman P, Siimes M . Percentile curves for hemoglobin and red cell volume in infancy and childhood. J Pediatr. 1979; 94(1):26-31. DOI: 10.1016/s0022-3476(79)80344-3. View

10.

Yoshida N, Yagasaki H, Takahashi Y, Yamamoto T, Liang J, Wang Y . Clinical impact of HLA-DR15, a minor population of paroxysmal nocturnal haemoglobinuria-type cells, and an aplastic anaemia-associated autoantibody in children with acquired aplastic anaemia. Br J Haematol. 2008; 142(3):427-35. DOI: 10.1111/j.1365-2141.2008.07182.x. View

11.

Dingli D, Luzzatto L, Pacheco J . Neutral evolution in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A. 2008; 105(47):18496-500. PMC: 2587638. DOI: 10.1073/pnas.0802749105. View

12.

Araten D, Bessler M, McKenzie S, Castro-Malaspina H, Childs B, Boulad F . Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones. Leukemia. 2002; 16(11):2243-8. DOI: 10.1038/sj.leu.2402694. View

13.

Sugimori C, Mochizuki K, Qi Z, Sugimori N, Ishiyama K, Kondo Y . Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure. Br J Haematol. 2009; 147(1):102-12. DOI: 10.1111/j.1365-2141.2009.07822.x. View

14.

Sloand E, Wu C, Greenberg P, Young N, Barrett J . Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy. J Clin Oncol. 2008; 26(15):2505-11. PMC: 6422026. DOI: 10.1200/JCO.2007.11.9214. View

15.

Maciejewski J, Follmann D, Nakamura R, Saunthararajah Y, Rivera C, Simonis T . Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome. Blood. 2001; 98(13):3513-9. DOI: 10.1182/blood.v98.13.3513. View

16.

Iwanaga M, Furukawa K, Amenomori T, Mori H, Nakamura H, Fuchigami K . Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes. Br J Haematol. 1998; 102(2):465-74. DOI: 10.1046/j.1365-2141.1998.00794.x. View